Search
ANI Pharmaceuticals Inc
ANIPAdd to Watchlist
79.490USD
-1.030-1.28%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.81BMarket Cap
19.32P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of ANI Pharmaceuticals Inc is 8.50, ranking 34 out of 157 in the Pharmaceuticals industry. The average price target is 107.50, with a high of 121.00 and a low of 90.00.
Analyst Rating
Based on
7
analysts
Buy
Current Rating
112.333
Target Price
+41.32%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
175
Total
6
Median
8
Average
Company name
Ratings
Analysts
ANI Pharmaceuticals Inc
ANIP
7
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Vertex Pharmaceuticals Inc
VRTX
34
1
2
3
...
35
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is ANI Pharmaceuticals Inc's expected revenue for the next quarter?
ANI Pharmaceuticals Inc's expected revenue is 262.14M.
What is ANI Pharmaceuticals Inc's price target?
Analysts forecast that ANI Pharmaceuticals Inc's price target is USD 107.50, with the highest forecast at USD 121.00 and the lowest forecast at USD 90.00.
How have ANI Pharmaceuticals IncANIP's recent earnings per share performed?
The market expectation was USD 1.31, while ANI Pharmaceuticals IncANIP's earnings per share (EPS) for the previous quarter was USD 1.23. EPS for the next quarter is expected at USD 2.01.
What is the analyst rating for ANI Pharmaceuticals Inc?
Based on the ratings of ANI Pharmaceuticals Inc's stock from 7 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
